Circassia Limited clinical trials
A subsidiary of NIOX Group plc
The registry lists 35 studies whose lead sponsor is Circassia Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 15, 2018.
- 35studies on the registry
- 0open to participants now
What it is testing
The drugs Circassia Limited’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
All 35 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3497%
- Stopped early13%
Over the years
- 08
- 09
- 10
- 811
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Circassia Limited35 studies
Something wrong with this grouping? Tell us on the NIOX Group plc page.
Studies
Recruiting first, then most recently updated. Showing 35 of 35. All NIOX Group plc studies →
- Phase III Cat-PAD Follow-on StudyCompletedNCT02040844Phase 3
Sponsor listed in the registry: Circassia Limited
- Phase III Cat-PAD StudyCompletedNCT01620762Phase 3
Sponsor listed in the registry: Circassia Limited
- Phase II HDM-SPIRE Safety and Efficacy StudyCompletedNCT02150343Phase 2
Sponsor listed in the registry: Circassia Limited
- Paediatric Safety Study in Cat-PADCompletedNCT01921257Phase 2
Sponsor listed in the registry: Circassia Limited
- Birch-SPIRE Safety and Efficacy StudyCompletedNCT02478060Phase 2
Sponsor listed in the registry: Circassia Limited
- Efficacy and Safety of Grass-SPIRE Registration StudyWithdrawnNCT02795273Phase 2/3
Sponsor listed in the registry: Circassia Limited
- Ragweed-SPIRE Follow-On StudyCompletedNCT02396680
Sponsor listed in the registry: Circassia Limited
- Grass Observational StudyCompletedNCT02075138
Sponsor listed in the registry: Circassia Limited
- Study of Grass-SPIRE in Subjects With Grass Allergies and AsthmaCompletedNCT02161107Phase 2
Sponsor listed in the registry: Circassia Limited
- Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure ChamberCompletedNCT02061709Phase 2
Sponsor listed in the registry: Circassia Limited
- Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and AsthmaCompletedNCT02061670Phase 2
Sponsor listed in the registry: Circassia Limited
- ToleroMune Grass Follow on StudyCompletedNCT02292875
Sponsor listed in the registry: Circassia Limited
- ToleroMune House Dust Mite (HDM) Tolerability StudyCompletedNCT01949441Phase 2
Sponsor listed in the registry: Circassia Limited
- Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array AnalysisCompletedNCT01383603Phase 1
Sponsor listed in the registry: Circassia Limited
- An Optional Investigation of Biomarkers of EfficacyCompletedNCT01949415
Sponsor listed in the registry: Circassia Limited
- ToleroMune House Dust Mite Follow on StudyCompletedNCT01923792
Sponsor listed in the registry: Circassia Limited
- House Dust Mite Observational StudyCompletedNCT01949428
Sponsor listed in the registry: Circassia Limited
- Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics AnalysisCompletedNCT01383590Phase 1
Sponsor listed in the registry: Circassia Limited
- ToleroMune Grass Follow on StudyCompletedNCT01923779
Sponsor listed in the registry: Circassia Limited
- ToleroMune Grass Exposure Unit StudyCompletedNCT01385800Phase 2
Sponsor listed in the registry: Circassia Limited
- Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis VulgarisCompletedNCT01743118Phase 1
Sponsor listed in the registry: Circassia Limited
- ToleroMune House Dust Mites (HDM) Exposure Chamber StudyCompletedNCT01447784Phase 2
Sponsor listed in the registry: Circassia Limited
- An Optional Two Year Follow Up Study to Study CP005ACompletedNCT01604018
Sponsor listed in the registry: Circassia Limited
- ToleroMune Ragweed Follow up StudyCompletedNCT01448603
Sponsor listed in the registry: Circassia Limited
- Ragweed Observational StudyCompletedNCT01398137
Sponsor listed in the registry: Circassia Limited
- Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed AllergyCompletedNCT01361412Phase 2
Sponsor listed in the registry: Circassia Limited
- ToleroMune Ragweed Exposure Chamber StudyCompletedNCT01198613Phase 2
Sponsor listed in the registry: Circassia Limited
- Cat-PAD Follow on StudyCompletedNCT01272323
Sponsor listed in the registry: Circassia Limited
- Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With RhinoconjunctivitisCompletedNCT01166061Phase 2
Sponsor listed in the registry: Circassia Limited
- Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With RhinoconjunctivitisCompletedNCT00878774Phase 2
Sponsor listed in the registry: Circassia Limited
- Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With RhinoconjunctivitisCompletedNCT01008332Phase 2
Sponsor listed in the registry: Circassia Limited
- Cat-PAD Exposure Chamber StudyCompletedNCT01033344Phase 2
Sponsor listed in the registry: Circassia Limited
- Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled AsthmaCompletedNCT00867906Phase 2
Sponsor listed in the registry: Circassia Limited
- Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic SubjectsCompletedNCT00729508Phase 2
Sponsor listed in the registry: Circassia Limited
- Safety of Cat-PAD in Cat Allergic SubjectsCompletedNCT00685711Phase 1/2
Sponsor listed in the registry: Circassia Limited